Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Franklin Resources Faces Critical Test with Upcoming Earnings

Felix Baarz by Felix Baarz
November 1, 2025
in Analysis, Banking & Insurance, Earnings
0
Franklin Stock
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Franklin Resources (NYSE: BEN) approaches a pivotal moment as it prepares to release its quarterly financial results on November 7th. The investment manager’s shares currently trade at $22.61, showing minimal movement in recent sessions, but this surface calm belies underlying market tensions. Growing skepticism among analysts and a notable increase in short positions suggest investors are bracing for potential volatility.

Mounting Bearish Pressure

Market sentiment toward Franklin Resources appears increasingly cautious. The consensus rating from brokerage firms currently stands at “Reduce,” indicating widespread concern among financial analysts. Barclays reinforced this negative outlook in late October by maintaining its “Underweight” designation and “Sell” recommendation. The average price target among covering firms sits at $23.83, though individual forecasts vary significantly from $19 to $29 per share.

The bearish case gains further support from short interest data, which shows that 7.72% of the company’s free float has been sold short. This substantial bearish bet equates to 5.1 days of average trading volume and recently increased by 6.77%, signaling deteriorating confidence among market participants.

Institutional Positioning Shows Divergence

Major institutional investors are sending mixed signals about Franklin’s prospects. During the second quarter, Sumitomo Mitsui Trust Group dramatically reduced its stake by 59.7%, liquidating over 500,000 shares. Meanwhile, other institutions took opposing positions: Teacher Retirement System of Texas established a new position valued at $811,000, while Mirae Asset Global Investments increased its existing holding by 5.9%. Overall, institutional investors control 47.56% of the company’s outstanding shares.

Should investors sell immediately? Or is it worth buying Franklin?

The upcoming earnings report will be scrutinized for signs that could either validate or alleviate current concerns. Investors will particularly examine assets under management, which climbed to $1.66 trillion by the end of September from $1.64 trillion the previous month. However, this positive development was partially offset by long-term net outflows totaling $11 billion.

Valuation Metrics Present Contrast

Franklin Resources carries a market capitalization of $11.74 billion, with its shares trading at a price-to-earnings multiple of 44.34 that many consider elevated. On a more positive note, the stock offers investors an attractive dividend yield of 5.62%. Recent recognition as “Asset Manager of the Year” in the over-$500 billion category has so far failed to meaningfully shift market sentiment.

All eyes now turn to Thursday’s earnings release, which will determine whether Franklin Resources can surpass skeptical expectations or confirm the prevailing bearish outlook.

Ad

Franklin Stock: Buy or Sell?! New Franklin Analysis from February 7 delivers the answer:

The latest Franklin figures speak for themselves: Urgent action needed for Franklin investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Franklin: Buy or sell? Read more here...

Tags: Franklin
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026
CrossFirst Bankshares Stock
Analysis

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
Next Post
NASDAQ 100 Stock

Tech Rally's Fragile Foundation: Amazon's Surge Masks Nasdaq 100 Weakness

Robinhood Stock

All Eyes on Robinhood as Quarterly Report Approaches

Wolfspeed Stock

Wolfspeed Shares Plunge on Bleak Financial Forecast

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com